Bank Of America Corp Lensar, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Lensar, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 27,811 shares of LNSR stock, worth $233,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,811

Previous 30,406 8.53%

Holding current value

$233,056

Previous $136,000 6.62%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.99 - $5.44 $10,354 - $14,116	-2,595 Reduced 8.53%	27,811 $127,000
Q2 2024 Aug 14, 2024	BUY	$3.0 - $4.88 $7,800 - $12,688	2,600 Added 9.35%	30,406 $136,000
Q1 2024 May 15, 2024	BUY	$3.25 - $5.0 $11,358 - $17,475	3,495 Added 14.38%	27,806 $94,000
Q4 2023 Feb 14, 2024	SELL	$2.01 - $3.51 $44 - $77	-22 Reduced 0.09%	24,311 $85,000
Q2 2023 Aug 14, 2023	BUY	$2.3 - $4.34 $50 - $95	22 Added 0.09%	24,333 $103,000
Q1 2023 May 12, 2023	BUY	$2.19 - $3.27 $48,703 - $72,721	22,239 Added 1073.31%	24,311 $60,000
Q4 2022 Feb 10, 2023	BUY	$2.7 - $5.9 $21 - $47	8 Added 0.39%	2,072 $6,000
Q3 2022 Nov 14, 2022	SELL	$4.94 - $7.0 $138 - $196	-28 Reduced 1.34%	2,064 $11,000
Q2 2022 Aug 12, 2022	BUY	$6.15 - $7.94 $8,997 - $11,616	1,463 Added 232.59%	2,092 $13,000
Q1 2022 May 16, 2022	BUY	$5.8 - $8.2 $1,258 - $1,779	217 Added 52.67%	629 $5,000
Q4 2021 Feb 08, 2022	SELL	$5.9 - $7.84 $519 - $689	-88 Reduced 17.6%	412 $3,000
Q3 2021 Nov 15, 2021	SELL	$7.5 - $8.88 $9,210 - $10,904	-1,228 Reduced 71.06%	500 $4,000
Q2 2021 Sep 13, 2021	BUY	$6.87 - $8.66 $11,871 - $14,964	1,728 New	1,728 $15,000

Others Institutions Holding LNSR

# of Institutions

Shares Held

4.91M

Call Options Held

700

Put Options Held

31.3K

View Full List

About LENSAR, Inc.

Ticker LNSR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 11,021,000
Market Cap $92.4M
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...

More about LNSR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Lensar, Inc. Transaction History